- Home
- TCRX vs LSBK Comparison
TCRX vs LSBK Comparison
Compare TCRX & LSBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRX
- LSBK
- Stock Information
- Founded
- TCRX 2018
- LSBK 1891
- Country
- TCRX United States
- LSBK United States
- Employees
- TCRX N/A
- LSBK N/A
- Industry
- TCRX Biotechnology: Pharmaceutical Preparations
- LSBK Savings Institutions
- Sector
- TCRX Health Care
- LSBK Finance
- Exchange
- TCRX Nasdaq
- LSBK Nasdaq
- Market Cap
- TCRX 82.1M
- LSBK 90.0M
- IPO Year
- TCRX 2021
- LSBK 2006
- Fundamental
- Price
- TCRX $1.93
- LSBK $12.15
- Analyst Decision
- TCRX Strong Buy
- LSBK
- Analyst Count
- TCRX 6
- LSBK 0
- Target Price
- TCRX $9.50
- LSBK N/A
- AVG Volume (30 Days)
- TCRX 572.1K
- LSBK 195.1K
- Earning Date
- TCRX 08-11-2025
- LSBK 07-23-2025
- Dividend Yield
- TCRX N/A
- LSBK 4.43%
- EPS Growth
- TCRX N/A
- LSBK 40.80
- EPS
- TCRX N/A
- LSBK 1.06
- Revenue
- TCRX $4,421,000.00
- LSBK $26,488,000.00
- Revenue This Year
- TCRX $159.20
- LSBK N/A
- Revenue Next Year
- TCRX N/A
- LSBK N/A
- P/E Ratio
- TCRX N/A
- LSBK $11.46
- Revenue Growth
- TCRX N/A
- LSBK 1.75
- 52 Week Low
- TCRX $1.02
- LSBK $11.50
- 52 Week High
- TCRX $7.44
- LSBK $12.50
- Technical
- Relative Strength Index (RSI)
- TCRX 63.03
- LSBK 62.69
- Support Level
- TCRX $1.75
- LSBK $11.50
- Resistance Level
- TCRX $1.96
- LSBK $12.38
- Average True Range (ATR)
- TCRX 0.14
- LSBK 0.25
- MACD
- TCRX 0.01
- LSBK 0.03
- Stochastic Oscillator
- TCRX 94.00
- LSBK 72.21
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About LSBK Lake Shore Bancorp Inc.
Lake Shore Bancorp Inc operates as a savings and loan holdings company. The bank's business consists of attracting retail deposits from the general public in the areas surrounding its branch offices and investing those deposits, together with funds generated from operations, in commercial real estate loans, one-to-four family residential mortgage loans, home equity lines of credit and to a lesser extent, commercial business loans, consumer loans, and investment securities. Its revenues are principally derived from interest earned on loans and investment securities.